1. HOME
  2. ABOUT US
    About Laekna Core Management Team Board of Directors Milestones Scientific Advisory Board Core Inverstors Honors & Awards
  3. R&D
    R&D Therapeutic Areas Candidates Pipeline Clinical Trials
  4. PARTNERSHIPS
    Strategic Partners Business Development Holistic Approach BD Contact
  5. INVESTORS
    Corporate Governance Financial Results Announcements and Circulars IR Calendar Listing Documents
  6. NEWS
    Press Releases Media Coverage
  7. CAREERS
    Global Team Career Development Jobs My Laekna
  8. CONTACT US
    Contact Us Leave Message
  9. RSS Feeds
 ABOUT US
GROUND-BREAKING THERAPEUTICS

Founded in 2016,

we are a clinical-stage biotechnology company

Learn More
Operation Team
Research & Development Team
in China and the US
 ABOUT US
GROUND-BREAKING THERAPEUTICS

Founded in 2016,

we are a clinical-stage biotechnology company

Learn More
Research & Development Team
in China and the US
Zhangjiang Pharma Valley, Shanghai, China
New Jersey, USA
Operation Team
Lingang, Shanghai
R&D
LEADING INNOVATION

Committed to bringing

novel therapies to

patients with cancer, metabolic diseases

and liver fibrosis

More in the pipeline

  1. 20

    projects in

    our pipeline


  2. 7

    clinical

    trials

  3. including3

    multi-regional clinical trials

    (MRCTs)

  4. including1

    phase III pivotal

    clinical trial

NEWS
LATEST ARTICLES
Learn More
  1. 2025-04-24
    Laekna Announces Two Poster Presentations on Internally Discovered Drug Candidates for Cancer at AACR 2025
    More
  2. 2025-04-23
    Laekna Releases 2024 ESG Report
    More
  3. 2025-03-31
    Announcement | Submission of IND Amendment to U.S. FDA for LAE102 for the Treatment of Obesity
    Learn More
    2025-03-26
    Laekna Announces First Visit for First Subject Completed in Phase I MAD Study of LAE102 for Obesity
    Learn More
NEWS
LATEST ARTICLES
Learn More
  1. 2025-04-24
    Laekna Announces Two Poster Presentations on Internally Discovered Drug Candidates for Cancer at AACR 2025
    More
  2. 2025-04-23
    Laekna Releases 2024 ESG Report
    More
  3. 2025-03-31
    Announcement | Submission of IND Amendment to U.S. FDA for LAE102 for the Treatment of Obesity
    More
CAREERS
OUR PEOPLE
Join Us
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
  1. Name*
  2. Email*
  3. Company
  4. Occupation

News

Positions

Follow us on Linkedin

  1. HOME
  2. ABOUT US
  3. R&D
  4. PARTNERSHIPS
  5. INVESTORS
  6. INVESTORS
  7. NEWS
  8. CAREERS

Copyright © Laekna Therapeutics, All Rights Reserved.  Privacy Policy

Follow us on Linkedin

Follow us on Wechat